News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Week in Review: China Kanghui Holdings Bought by Medtronic, Inc. (MDT) for $816 Million



10/1/2012 11:40:49 AM

by Richard Daverman, PhD

September 29, 2012 -- China Kanghui Holdings will be acquired by fellow medical device maker Medtronic for $816 million; China Nuokang Bio-Pharma accepted a go-private offer that values the company at $114 million; Medicago, a Canadian vaccines company, has out-licensed China rights to its pandemic and seasonal flu vaccines to cigarette maker Philip Morris Products in a $12 million deal; BGI of Shenzhen will build a next generation sequencing facility in Singapore in a diagnostics partnership with INEX Innovations; Novo Nordisk officially opened a new $100 million R&D center in Beijing; Neuralstem was granted SFDA approval to begin a clinical trial in China of its spinal cord stem cell product as a treatment for stroke; and the BayHelix Group together with Elsevier Business Intelligence handed out four awards for innovation in China pharma development. More detailsā€¦.

Stock Symbols: (NYSE: KH) (NYSE: MDT) (NSDQ: NKBP) (TSX: MDG) (NYSE: NVO) (NYSE: CUR)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES